Indraprastha Apollo Hospital
India's leading tertiary care hospital, JCI and NABH accredited with 710+ beds, proton therapy network access, CAR-T cell therapy, da Vinci robotic surgery, and bone marrow transplant — serving cancer patients from over 120 countries.
About Indraprastha Apollo Hospital
Indraprastha Apollo Hospital, New Delhi, is one of India's foremost tertiary-care hospitals and a leading destination for international cancer patients. Established in 1996 under the Apollo Hospitals group, it houses over 710 beds, 116 ICU beds, and 11 state-of-the-art operation theatres. The hospital is recognised for pioneering advanced oncology treatments in India, including proton therapy network access, da Vinci robotic surgery, CAR-T cell therapy, and bone marrow transplantation. It holds JCI, NABH, and NABL accreditations, reflecting its commitment to international-grade clinical standards.
The hospital's oncology programme is structured around multidisciplinary tumour board review covering the full spectrum of cancers — blood cancers (leukaemia, lymphoma, myeloma), solid tumours (breast, lung, colorectal, gastric, hepatobiliary, head and neck, urological, gynaecological), brain tumours, and paediatric oncology. Advanced capabilities include haematopoietic stem cell transplantation (HSCT), CAR-T cell immunotherapy, da Vinci Xi robotic oncologic surgery (4th generation, India's first site-specific robotic oncology team), IMRT/IGRT/SRS/SBRT radiation therapy, HIPEC for peritoneal carcinomatosis, and targeted therapy and immunotherapy across DCGI- and FDA-approved agents. Apollo patients also have access to proton therapy through the Apollo Proton Cancer Centre within the wider Apollo network.
CancerFax works directly with Indraprastha Apollo Hospital's International Patient Services division to help patients worldwide access its specialist oncology programmes. From submitting medical records and securing a clinical review to coordinating Indian medical visa documentation, interpreters, and pre-arrival logistics, CancerFax manages the entire process at no cost to the patient — ensuring families who need Apollo Delhi's expertise can reach it without logistical barriers.
| Hospital at a Glance | |
|---|---|
| Country | India |
| City | New Delhi (Sarita Vihar, South Delhi) |
| Established | 1996 |
| Hospital Type | Multi-Specialty Tertiary Care Hospital — Apollo Hospitals group |
| Accreditation | JCI · NABH · NABL |
| Beds | 710+ beds, 116 ICU beds, 11 operation theatres |
| Annual Cancer Patients | ⚠ VERIFY with hospital; Apollo Network treats 100,000+ cancer patients annually across India |
| Key Cancer Programmes | CAR-T Cell Therapy · Bone Marrow Transplant · da Vinci Robotic Surgery · Proton Therapy (network) · HIPEC · IMRT/IGRT/SRS/SBRT |
Why Patients Choose Apollo Delhi for Cancer Treatment
Indraprastha Apollo Hospital combines India's highest quality private-sector oncology infrastructure with genuine subspecialty depth across haematological malignancies, solid tumour surgery, radiation oncology, and cellular therapy — supported by JCI accreditation, international patient services serving 120+ countries, and full Apollo network resource access.
Cancer Specialties and Clinical Departments
Indraprastha Apollo Hospital offers comprehensive cancer care across medical, surgical, and radiation oncology sub-specialties, with particular depth in haematologic malignancies (CAR-T, BMT), robotic surgical oncology, and advanced radiation therapy.
Advanced Treatment Capabilities
Key Specialists at Apollo Delhi
Indraprastha Apollo Hospital's oncology leadership includes some of India's most experienced cancer specialists. Dr. Gaurav Kharya, Director and Head of Bone Marrow Transplant, Cellular Therapy and Immune Modulation, is one of India's leading cellular therapy specialists, recognised for paediatric and adult BMT, CAR-T cell therapy, and haploidentical transplants. Dr. Shishir Seth, Senior Consultant in Haematology and Medical Oncology, brings deep expertise in leukaemia, lymphoma, myeloma, and stem cell transplantation.
The wider oncology team covers surgical oncology, radiation oncology, and medical oncology across all major cancer types. CancerFax matches patients with the most appropriate Apollo Delhi specialist based on their specific cancer diagnosis, prior treatment history, and clinical requirements — and confirms the named consultant who will lead the case before any travel commitment. Patients can request specialist matching through CancerFax at no cost.
⚠ VERIFY: Current heads of Surgical Oncology and Radiation Oncology departments. CancerFax can confirm the most appropriate specialist for each case.
Clinical Infrastructure and Treatment Technology
Indraprastha Apollo Hospital operates 710+ beds, 116 ICU beds, 11 modular operation theatres, and advanced imaging across a purpose-built tertiary care campus in South Delhi, supported by the wider Apollo network's research and technology resources.
- CAR-T cell therapy for relapsed/refractory B-cell ALL and DLBCL under Dr. Gaurav Kharya
- Autologous and allogeneic HSCT including matched unrelated donor (MUD) and haploidentical transplants
- Dedicated bone marrow transplant unit with HEPA-filtered laminar flow wards
- 11 modular operation theatres; da Vinci Xi 4th-generation robotic surgical system
- India's first site-specific robotic oncology team: prostatectomy, hysterectomy, colorectal, thoracic, head and neck
- HIPEC (Hyperthermic Intraperitoneal Chemotherapy) for peritoneal carcinomatosis
- Full radiation suite: IMRT, IGRT, SRS, SBRT; proton therapy network access via Apollo Proton Cancer Centre
- 3T MRI, 256-slice CT, PET-CT imaging for staging and treatment planning
- Nuclear medicine department with diagnostic and therapeutic capabilities
- NABL-accredited laboratories; molecular profiling and NGS for targeted therapy selection
- 116 ICU beds across specialised critical care units; 24/7 Blood Bank and Transfusion Medicine
- In-house pharmacy (24/7); rehabilitation, physiotherapy, and nutritional support
International Patient Support at Apollo Delhi
Indraprastha Apollo Hospital's International Patient Services division serves patients from over 120 countries annually with multilingual coordinators, a dedicated patient lounge, visa letter facilitation, airport transfers, and hotel tie-ups.
What to Prepare Before Traveling
- arrow_rightShare complete pathology reports, biopsy slides where available for re-review, recent CT/PET-CT/MRI imaging, molecular profiling, prior treatment summaries, and a current medication list (in English) with CancerFax at least one to two weeks before your planned Apollo Delhi consultation.
- arrow_rightApply for an Indian medical visa (M visa) at the Indian high commission or consulate in your country. Apollo Delhi can issue an official invitation letter for the patient and up to two accompanying family members.
- arrow_rightPlan travel via Indira Gandhi International Airport (DEL), approximately 15 km from the hospital. Allow at least one to two weeks for an initial consultation and multidisciplinary tumour board review, with longer stays for BMT (4-8 weeks), robotic surgery (3-7 days), or radiation therapy courses (3-6 weeks).
Apollo Delhi can be contacted directly via apollohospitals.com/delhi. CancerFax coordinates all enquiries, manages medical record review, and provides honest comparison with other Indian cancer hospitals and international alternatives at no cost to the patient.
Patient Facilities and Accommodation at Apollo Delhi
Indraprastha Apollo Hospital provides comprehensive inpatient accommodation across its 710+ bed campus with 116 ICU beds, 24/7 emergency and pharmacy services, and a dedicated international patient lounge.
Family members accompanying international patients can stay at hotels near the Apollo Delhi campus in Sarita Vihar and the broader South Delhi area. The hospital is approximately 15 km from Indira Gandhi International Airport. CancerFax can assist with extended-stay accommodation planning for families during BMT, radiation therapy, or longer surgical recovery stays.
How to Reach Indraprastha Apollo Hospital
Apollo Delhi is located in Sarita Vihar along the Delhi-Mathura Road (NH-2) in South Delhi, approximately 15 km from Indira Gandhi International Airport and well connected by the Delhi Metro Violet Line.
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination — travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.
Apollo Delhi — Patient Questions Answered
Yes. The Bone Marrow Transplant and Cellular Therapy department under Dr. Gaurav Kharya offers CAR-T cell therapy for eligible patients with relapsed or refractory B-cell malignancies including B-cell ALL and DLBCL. CancerFax can help assess CAR-T eligibility based on your diagnosis and prior treatment history, and compare Apollo Delhi's programme with other Indian and international CAR-T centres before any travel commitment.
Apollo Delhi patients have access to proton therapy through the Apollo Proton Cancer Centre in Chennai within the Apollo network. Coordination and referral are managed internally within the Apollo network. CancerFax can help clarify whether proton therapy is clinically indicated for your case and whether the Apollo network's proton centre or an alternative international proton facility would be the right clinical fit.
International patients can reach out through CancerFax for end-to-end coordination, or contact Apollo's International Patient Services directly via apollohospitals.com/delhi. CancerFax handles medical record review, specialist matching, visa documentation, accredited report translation, and travel logistics at no cost to the patient — and will confirm the named senior consultant who will see the patient at their first appointment before any travel is committed.
Yes. Both Apollo's International Patient Services and CancerFax can assist with Indian medical visa (M visa) invitation letters and documentation support. Apollo Delhi is a well-established international hospital recognised by Indian immigration for medical visa purposes.
As a leading Indian private hospital, Apollo Delhi offers cancer treatment at typical Indian private hospital pricing, which is materially lower than equivalent care in Singapore, the UAE, the UK, or the US. CancerFax shares Apollo Delhi's official cost estimates with you at no mark-up and will compare them openly with other Indian cancer hospitals (AIIMS, Tata Memorial, BLK-Max) and international alternatives before any decision is made.
Send Your Medical Reports to Indraprastha Apollo Hospital via CancerFax
CancerFax reviews your records, identifies whether Apollo Delhi, a specialist Indian cancer centre, or an international option is the right clinical fit, and coordinates your consultation at no cost, with no obligation, and with full medical confidentiality throughout.